Yonhap Infomax NewsOct 31
Yuhan Corp. will receive a $45 million milestone payment from Janssen Biotech after the commercial launch of Leclaza in China, marking a key step in its global expansion strategy.
#YonhapInfomax #YuhanCorp #Leclaza #JanssenBiotech #MilestonePayment #ChinaLaunch #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=88599
Yuhan Corp. Receives $45 Million Milestone Payment for 'Leclaza' Following Commercial Launch in China

Yuhan Corp. will receive a $45 million milestone payment from Janssen Biotech after the commercial launch of Leclaza in China, marking a key step in its global expansion strategy.

Yonhap Infomax
Yonhap Infomax NewsMay 30, 2025
Yuhan Corp. will receive a $15 million (20.7 billion won) milestone payment from Janssen Biotech after its lung cancer drug Leclaza was officially launched in Japan, marking a key step in the drug's global commercialization.
#YonhapInfomax #YuhanCorp #Leclaza #JanssenBiotech #MilestonePayment #JapanLaunch #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=65606
Yuhan to Receive 20.7 Billion Won in Royalties as Leclaza Launches Commercially in Japan

Yuhan Corp. will receive a $15 million (20.7 billion won) milestone payment from Janssen Biotech after its lung cancer drug Leclaza was officially launched in Japan, marking a key step in the drug's global commercialization.

Yonhap Infomax